Intriguing, but Not the Right Setting

Stereotactic body radiation therapy (SBRT) offers an intriguing treatment option for men with oligometastatic prostate cancer. Several series document that treatment of bony and nodal targets is associated with high local control and minimal toxicity (1). The use of SBRT to defer treatment with androgen deprivation therapy (ADT) (median 28 months in reference [1]) suggests a significant quality of life benefit.

http://ift.tt/2r5NjZ8